Hofbauer LC - Search Results

1

Disruption of a nuclear NFATc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acid.

Singh SK, Baumgart S, Singh G, König AO, Reutlinger K, Hofbauer LC, Barth P, Gress TM, Lomberk G, Urrutia R, Fernandez-Zapico ME, Ellenrieder V. Singh SK, et al. Among authors: hofbauer lc. J Biol Chem. 2011 Aug 19;286(33):28761-28771. doi: 10.1074/jbc.M110.197533. Epub 2011 May 31. J Biol Chem. 2011. PMID: 21628454 Free PMC article.

2

VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.

Zielke A, Middeke M, Hoffmann S, Colombo-Benkmann M, Barth P, Hassan I, Wunderlich A, Hofbauer LC, Duh QY. Zielke A, et al. Among authors: hofbauer lc. Surgery. 2002 Dec;132(6):1056-63; discussion 1063. doi: 10.1067/msy.2002.128613. Surgery. 2002. PMID: 12490855

3

Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis.

Schoppet M, Al-Fakhri N, Franke FE, Katz N, Barth PJ, Maisch B, Preissner KT, Hofbauer LC. Schoppet M, et al. Among authors: hofbauer lc. J Clin Endocrinol Metab. 2004 Aug;89(8):4104-12. doi: 10.1210/jc.2003-031432. J Clin Endocrinol Metab. 2004. PMID: 15292354

4

Osteoporosis in patients with diabetes mellitus.

Hofbauer LC, Brueck CC, Singh SK, Dobnig H. Hofbauer LC, et al. J Bone Miner Res. 2007 Sep;22(9):1317-28. doi: 10.1359/jbmr.070510. J Bone Miner Res. 2007. PMID: 17501667 Free article. Review.

5

Fatal attraction: why breast cancer cells home to bone.

Hofbauer LC, Rachner T, Singh SK. Hofbauer LC, et al. Breast Cancer Res. 2008;10(1):101. doi: 10.1186/bcr1848. Epub 2008 Jan 25. Breast Cancer Res. 2008. PMID: 18226190 Free PMC article.

6

Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis.

Rachner TD, Benad P, Rauner M, Goettsch C, Singh SK, Schoppet M, Hofbauer LC. Rachner TD, et al. Among authors: hofbauer lc. J Cell Biochem. 2009 Sep 1;108(1):106-16. doi: 10.1002/jcb.22232. J Cell Biochem. 2009. PMID: 19544400

7

Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells.

Rachner TD, Singh SK, Schoppet M, Benad P, Bornhäuser M, Ellenrieder V, Ebert R, Jakob F, Hofbauer LC. Rachner TD, et al. Among authors: hofbauer lc. Cancer Lett. 2010 Jan 1;287(1):109-16. doi: 10.1016/j.canlet.2009.06.003. Epub 2009 Jul 3. Cancer Lett. 2010. PMID: 19577359

8

Seizures associated with zoledronic acid for osteoporosis.

Tsourdi E, Rachner TD, Gruber M, Hamann C, Ziemssen T, Hofbauer LC. Tsourdi E, et al. Among authors: hofbauer lc. J Clin Endocrinol Metab. 2011 Jul;96(7):1955-9. doi: 10.1210/jc.2011-0418. Epub 2011 Apr 20. J Clin Endocrinol Metab. 2011. PMID: 21508139

9

Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins.

Göbel A, Browne AJ, Thiele S, Rauner M, Hofbauer LC, Rachner TD. Göbel A, et al. Among authors: hofbauer lc. Breast Cancer Res Treat. 2015 Dec;154(3):623-31. doi: 10.1007/s10549-015-3624-8. Epub 2015 Oct 29. Breast Cancer Res Treat. 2015. PMID: 26515701

10

Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells.

Göbel A, Thiele S, Browne AJ, Rauner M, Zinna VM, Hofbauer LC, Rachner TD. Göbel A, et al. Among authors: hofbauer lc. Cancer Lett. 2016 May 28;375(1):162-171. doi: 10.1016/j.canlet.2016.03.004. Epub 2016 Mar 8. Cancer Lett. 2016. PMID: 26968247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

440 results

Search Page